TCTMD Articles

Jun 26, 2020 | TCTMD Articles
No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

There is no survival advantage with invasive coronary revascularization over medical therapy in patients with stable ischemic heart disease, but revascularization does reduce the incidence of unstable angina and provides greater symptom relief, according to the results of a new study-level meta-analysis.

Featured Article

Jun 25, 2020 | TCTMD Articles
Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

Asmall series of autopsies from COVID-19 patients in New York confirms prior observations about severe hypercoagulability and shows the presence of platelet-rich blood clots in major organs, including the heart.

Jun 18, 2020 | TCTMD Articles
Bernard J. Tyson’s legacy flourishes as new impact fund drives his vision for social justice and equitable healthcare forward

The American Heart Association (AHA), the world’s leading nonprofit organization focused on heart and brain health for all, launches the Bernard J. Tyson Impact Fund to invest in solutions designed to break down the social and economic barriers to health equity.

Jun 16, 2020 | TCTMD Articles
Dexamethasone Cuts Death by One-Third in Ventilated COVID-19 Patients

The use of the corticosteroid dexamethasone in COVID-19 patients on mechanical ventilation cuts the risk of all-cause mortality by roughly one-third, while also lowering the risk of death in patients requiring oxygen, according to early data from the RECOVERY trial.

Jun 10, 2020 | TCTMD Articles
SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Among the small fraction of patients who undergo redo surgery for a failed TAVR device, outcomes are worse than for those receiving initial surgical aortic valve replacement, according to registry data.

Jun 2, 2020 | TCTMD Articles
Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope

In the race to save lives, physicians have turned to extracorporeal membrane oxygenation (ECMO) and, more rarely, other forms of mechanical circulatory support (MCS) to overcome lung and sometimes cardiac complications of COVID-19.

May 27, 2020 | TCTMD Articles
Drug-Coated Balloons for CAD: Some International Consensus

An international drug-coated balloon (DCB) consensus group has issued updated guidance on the use of these devices in coronary arteries, with an emphasis on emerging indications and forthcoming technologies.

May 21, 2020 | TCTMD Articles
Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Physiologic pacing of the His-Purkinje conduction system is feasible in patients who require a permanent pacemaker following TAVR and this alternative pacing method did not interfere with ejection fraction recovery in patients with reduced LV function at baseline, according to the results of a new retrospective study.

May 8, 2020 | TCTMD Articles
Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability

In cities hit hardest by COVID-19, another perplexing problem has emerged: younger patients who test positive for the virus are presenting to hospital with large-vessel strokes and—in some cases—no traditional stroke risk factors.

May 1, 2020 | TCTMD Articles
FDA: Class I Recall for Vascular Solutions’ Dual Lumen Catheters

Vascular Solutions, Inc. has announced it is recalling the Langston Dual Lumen Catheter in response to reports that the inner catheter may separate during use. The US Food and Drug Administration has deemed it a Class I device recall, the most serious type.